First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma-An Update on Patient Selection and Response Evaluation
about
Focal Adhesion Kinase: Insight into Molecular Roles and Functions in Hepatocellular CarcinomaAdjuvant celecoxib and lanreotide following transarterial chemoembolisation for unresectable hepatocellular carcinoma: a randomized pilot study.A proteomics-based investigation on the anticancer activity of alisertib, an Aurora kinase A inhibitor, in hepatocellular carcinoma Hep3B cells.
P2860
First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma-An Update on Patient Selection and Response Evaluation
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
First- and Second-Line Targete ...... ection and Response Evaluation
@ast
First- and Second-Line Targete ...... ection and Response Evaluation
@en
First- and Second-Line Targete ...... ection and Response Evaluation
@nl
type
label
First- and Second-Line Targete ...... ection and Response Evaluation
@ast
First- and Second-Line Targete ...... ection and Response Evaluation
@en
First- and Second-Line Targete ...... ection and Response Evaluation
@nl
prefLabel
First- and Second-Line Targete ...... ection and Response Evaluation
@ast
First- and Second-Line Targete ...... ection and Response Evaluation
@en
First- and Second-Line Targete ...... ection and Response Evaluation
@nl
P2093
P2860
P1476
First- and Second-Line Targete ...... ection and Response Evaluation
@en
P2093
Henning Wege
Ines Gil-Ibanez
Johann von Felden
Kornelius Schulze
Tobias Werner
P2860
P356
10.3390/DIAGNOSTICS6040044
P407
P577
2016-11-28T00:00:00Z